2020
Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood
Li S, Crawford FW, Gerstein MB. Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood. Nature Communications 2020, 11: 3575. PMID: 32681003, PMCID: PMC7368050, DOI: 10.1038/s41467-020-17388-x.Peer-Reviewed Original Research
2018
Estimating dose-specific cell division and apoptosis rates from chemo-sensitivity experiments
Liu Y, Crawford FW. Estimating dose-specific cell division and apoptosis rates from chemo-sensitivity experiments. Scientific Reports 2018, 8: 2705. PMID: 29426887, PMCID: PMC5807362, DOI: 10.1038/s41598-018-21017-5.Peer-Reviewed Original Research